Oxandrolone

CAS 53-39-4 5 current records 6 historicalSmall Molecule

Who holds supplier records for Oxandrolone? 5 organisations hold a current record for Oxandrolone: an active US FDA Type II Drug Master File. A further 6 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: Italy (2) and United States (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Oxandrolone: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/oxandrolone

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in Italy

    2 of the 3 current records with a recorded country list Italy. Organisation country is not necessarily the manufacturing site.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Oxandrolone. Country is the organisation's recorded country, not necessarily the manufacturing site.

Italy2United States1Country not recorded for 2
  • CURIA ITALY SRL
    Active DMF 34723 · latest filing Mar 2020
    Italy Company GMP cert on record
  • HIKMA PHARMACEUTICALS
    Active DMF 20344 · latest filing Mar 2007
  • NOVITIUM PHARMA LLC
    Active DMF 31920 · latest filing Oct 2017
    United States
  • SIEGFRIED GRAFTON INC
    Active DMF 16598 · latest filing May 2003
  • TRIFARMA SPA
    Active DMF 17962 · latest filing Jan 2005
    Italy Company GMP cert on record
Need Oxandrolone sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (6)

Organisations whose Type II DMFs for Oxandrolone are no longer active. These show a past filing, not current supply.

Show all 6 historical records
  • JOHNSON MATTHEY PHARMACEUTICAL MATERIALS
    Inactive DMF 19466 · filed May 2006
  • United States · Inactive DMF 17459 · filed Jun 2004
  • Taiwan · Inactive DMF 16938 · filed Oct 2003
  • AMRI ITALY SRL
    Inactive DMF 16849 · filed Sept 2003
  • Italy · Inactive DMF 16217 · filed Oct 2002
  • Hungary · Inactive DMF 15427 · filed May 2001

Overview

Oxandrolone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200436).

Chemical identity

IUPAC name
(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one
Canonical SMILES
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(COC(=O)C4)C
InChIKey
QSLJIVKCVHQPLV-PEMPUTJUSA-N
Synonyms
Anavar, Lonavar, NSC-67068, Oxandrin, Oxandrolona, Oxandrolone, Oxandrolone ciii, Provitar, SC 11585, SC-11585, Vasorome, Protivar

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Oxandrolone?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Oxandrolone: CURIA ITALY SRL (Italy), HIKMA PHARMACEUTICALS, NOVITIUM PHARMA LLC (United States), SIEGFRIED GRAFTON INC and TRIFARMA SPA (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Oxandrolone Drug Master Files are active?

CURIA ITALY SRL (DMF 34723), HIKMA PHARMACEUTICALS (DMF 20344), NOVITIUM PHARMA LLC (DMF 31920), SIEGFRIED GRAFTON INC (DMF 16598) and TRIFARMA SPA (DMF 17962). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Oxandrolone records mean?

6 organisations have only inactive Type II DMFs for Oxandrolone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Oxandrolone supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Oxandrolone?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.